APM
TECH icon

Advanced Portfolio Management’s Bio-Techne TECH Stock Holding History

Advanced Portfolio Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-22,028
Closed -$1.7M – 77
2023
Q4 		$1.7M Buy
+22,028
New +$1.45M 1.79% 17

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Advanced Portfolio Management's TECH Position: Q1 2024 in Review

Advanced Portfolio Management sold out of Bio-Techne (TECH) in Q1 2024, closing a stake of 22,028 shares — an estimated $1.7M sold.

Advanced Portfolio Management first reported a position in TECH in Q4 2023 and held it in 1 quarter. The position peaked at $1.7M in Q4 2023. 557 funds tracked by Wall St. Rank hold TECH as of Q1 2024.

  • Advanced Portfolio Management reported no remaining Bio-Techne position as of Q1 2024 after selling out during the quarter.
  • Advanced Portfolio Management sold 22,028 Bio-Techne shares in Q1 2024, an estimated $1.7M.
  • Advanced Portfolio Management first reported a position in Bio-Techne in Q4 2023 and held it in 1 quarter.
  • Advanced Portfolio Management's Bio-Techne position peaked at $1.7M in Q4 2023.
  • 557 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2024.

Based on Advanced Portfolio Management's 13F filing for Q1 2024, filed 15 May 2024.